We are live on ! Find out more
IMA

ImageneBio Inc

54 hedge funds and large institutions have $63.9M invested in ImageneBio Inc in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 28 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 12

0.62% less ownership

Funds ownership: 6.22%5.6% (-0.62%)

7% less funds holding

Funds holding: 5854 (-4)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

50% less funds holding in top 10

Funds holding in top 10: 42 (-2)

55% less capital invested

Capital invested by funds: $142M → $63.9M (-$77.6M)

Holders
54
Holders Change
-4
Holders Change %
-6.9%
% of All Funds
0.79%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
6
Increased
28
Reduced
12
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$169K +$44K +1,351 +23%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$136K
Jacobs Levy Equity Management
28
Jacobs Levy Equity Management
New Jersey
$111K -$2.87K -88 -2%
Two Sigma Investments
29
Two Sigma Investments
New York
$100K +$79.3K +2,433 +134%
Bank of America
30
Bank of America
North Carolina
$98.5K +$54.9K +1,684 +68%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$76.3K -$128K -3,916 -55%
N
32
Nuveen
North Carolina
$71.6K +$8.97K +275 +10%
CIC
33
Cornercap Investment Counsel
Georgia
$71.2K -$2.97K -91 -3%
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$53K +$4.17K +128 +6%
VF
35
Virtu Financial
New York
$53K +$41.3K +1,267 +130%
Goldman Sachs
36
Goldman Sachs
New York
$46.5K +$6K +184 +10%
JP Morgan Chase
37
JP Morgan Chase
New York
$44K +$15.9K +488 +36%
Jane Street
38
Jane Street
New York
$43.5K +$60K +1,839 New
UBS Group
39
UBS Group
Switzerland
$41.5K +$20.2K +620 +54%
Acadian Asset Management
40
Acadian Asset Management
Massachusetts
$41K +$31.3K +960 +113%
SG Americas Securities
41
SG Americas Securities
New York
$40K +$25.8K +791 +88%
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$39.7K +$54.8K +1,681 New
AIG
43
American International Group
New York
$30.3K +$8.12K +249 +24%
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$29.5K -$196 -6 -0.5%
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$21K +$18K +552 +155%
Invesco
46
Invesco
Georgia
$20K +$27.6K +847 New
Wells Fargo
47
Wells Fargo
California
$18.7K +$9.1K +279 +55%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$10K -$1.04K -32 -7%
TRCT
49
Tower Research Capital (TRC)
New York
$9.84K +$3.49K +107 +35%
Citigroup
50
Citigroup
New York
$9.12K +$12.6K +385 +38,500%

IMA Hedge Fund Activity: Q4 2023 in Review

54 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q4 2023, worth a combined $63.9M — down 55% from $142M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of IMA and 6 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 28 added.

The largest buyer was Blue Owl Capital Holdings, opening a new position worth an estimated $5.31M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $7.1M sold.

  • 54 institutional investors held ImageneBio Inc (IMA) as of Q4 2023, down from 58 in Q3 2023.
  • Funds reported $63.9M of ImageneBio Inc stock for Q4 2023, down 55% quarter-over-quarter.
  • 6 funds opened new ImageneBio Inc positions in Q4 2023 and 8 closed out, a net change of -2 holders.
  • The largest ImageneBio Inc buyer in Q4 2023 was Blue Owl Capital Holdings, an estimated $5.31M added.
  • The largest ImageneBio Inc seller in Q4 2023 was Avoro Capital Advisors, an estimated $7.1M sold.

Based on aggregated 13F filings for Q4 2023.